Global API micronization market set to surge 49% by 2030, led by specialized industry pioneers

Data Compilation
#PharmaFlow

Pipeline Prospector September 2025: Genmab buys Merus for ~US$ 8 billion, Pfizer buys Metsera to enter obesity race

Stock Recap
#PipelineProspector

VIMOVO

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

209 API Suppliers, 66 USDMF, 50 CEP/COS, 7 JDMF, 49 EU WC, 83 KDMF, 47 NDC API, 66 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

101 Drugs in Development

101 Drugs in Development

INTERMEDIATES

15 Intermediate Suppliers

15 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

873 FDF Dossiers, 105 FDA Orange Book, 317 Europe, 23 Canada, 145 Australia, 68 South Africa, 215 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE, DELAYED RELEASE;ORAL - EQ 20MG BASE, CAPSULE, DELAYED REL PELLETS;ORAL - EQ 20MG BASE, CAPSULE, DELAYED REL PELLETS;ORAL - EQ 40MG BASE, FOR SUSPENSION, DELAYED RELEASE;ORAL - EQ 2.5MG BASE/PACKET, FOR SUSPENSION, DELAYED RELEASE;ORAL - EQ 20MG BASE/PACKET, FOR SUSPENSION, DELAYED RELEASE;ORAL - EQ 40MG BASE/PACKET, FOR SUSPENSION, DELAYED RELEASE;ORAL - EQ 5MG BASE/PACKET, TABLET, DELAYED RELEASE;ORAL - EQ 20MG BASE;375MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, DELAYED RELEASE;ORAL - EQ 20MG BASE;500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Minakem, 7 Evonik, 1 Rochem International Inc, 18 SPI Pharma, 10 DKSH, 3 Boai NKY Pharmaceuticals Ltd, 6 Gangwal Healthcare, 4 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 2 Pfanstiehl, 4 Kirsch Pharma, 4 ACG Worldwide, 6 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 30 BASF, 2 CD Formulation, 15 Corel Pharma Chem, 3 DFE Pharma, 3 Doshion Polyscience, 1 Esteem Industries, 2 Finar, 11 Gangwal Chemicals, 12 Ideal Cures, 4 Ingredion Pharma Solutions, 11 Kerry, 2 Keval Exports, 4 Kima Chemical, 6 Lonza Capsugel, 11 Microlex e.U, 2 Nanjing Bold Chemical, 3 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 2 Novo Excipients, 3 Pharmatrans-Sanaq, 6 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 18 Roquette, 14 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 10 Sigachi Industries, 3 Silverline Chemicals, 3 The Dow Chemical Company, 1 Ulanqab Kema New Material, 2 Valens Pharmachem, 3 Vasa Pharmachem, 1 Vertellus

EXCIPIENTS BY APPLICATIONS

67 Fillers, Diluents & Binders, 66 Coating Systems & Additives, 39 Controlled & Modified Release, 34 Solubilizers, 33 Thickeners and Stabilizers, 29 Direct Compression, 27 Taste Masking, 25 Granulation, 23 Disintegrants & Superdisintegrants, 21 Lubricants & Glidants, 19 Chewable & Orodispersible Aids, 18 Film Formers & Plasticizers, 18 Topical, 16 Parenteral, 14 Co-Processed Excipients, 10 Emulsifying Agents, 9 Empty Capsules, 6 Surfactant & Foaming Agents, 6 Rheology Modifiers, 5 API Stability Enhancers, 5 Coloring Agents, 4 Vegetarian Capsules

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 154 News #PharmaBuzz

GLOBAL SALES INFORMATION

23 US Medicaid Prescriptions, 243 Regulatory FDF Prices, 18 Annual Reports

MARKET PLACE

68 APIs, 36 FDF Dossiers

PATENTS & EXCLUSIVITIES

2 US Patents, 40 Health Canada Patents

REF. STANDARDS & IMPURITIES

5 EDQM, 1 USP, 21 Others

ANALYTICAL

2 BioAnalytical Methods

2 BioAnalytical Methods

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Certificate Holder	Certificate No.	Substance	Issue Date	Status	Type	End Date	Substance No.
27/09/2025	Minakem	France	MINAKEM Dunkerque FR	R1-CEP 2012-256 - Rev 02	Esomeprazole magnesium trihydrate, Micronised, non-micronised	2021-06-03	Valid	Chemical		2372
27/09/2025	Metrochem API Private Limited	India	METROCHEM API PRIVATE LIMITED Hyderabad IN	CEP 2021-022 - Rev 01	Esomeprazole magnesium dihydrate	2024-06-20	Valid	Chemical		2787

VIMOVO

VIMOVO

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

209 API Suppliers

66 USDMF

50 CEP/COS

7 JDMF

49 EU WC

83 KDMF

47 NDC API

66 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

101 Drugs in Development

INTERMEDIATES

15 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

873 FDF Dossiers

105 FDA Orange Book

317 Europe

23 Canada

145 Australia

68 South Africa

215 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE, DELAYED RELEASE;ORAL - EQ 20MG BASE

CAPSULE, DELAYED REL PELLETS;ORAL - EQ 20MG BASE

CAPSULE, DELAYED REL PELLETS;ORAL - EQ 40MG BASE

FOR SUSPENSION, DELAYED RELEASE;ORAL - EQ 2.5MG BASE/PACKET

FOR SUSPENSION, DELAYED RELEASE;ORAL - EQ 20MG BASE/PACKET

FOR SUSPENSION, DELAYED RELEASE;ORAL - EQ 40MG BASE/PACKET

FOR SUSPENSION, DELAYED RELEASE;ORAL - EQ 5MG BASE/PACKET

TABLET, DELAYED RELEASE;ORAL - EQ 20MG BASE;375MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, DELAYED RELEASE;ORAL - EQ 20MG BASE;500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Minakem

7 Evonik

1 Rochem International Inc

18 SPI Pharma

10 DKSH

3 Boai NKY Pharmaceuticals Ltd

6 Gangwal Healthcare

4 Nanjing Well Pharmaceutical

1 Shanghai Minbiotech

2 Pfanstiehl

4 Kirsch Pharma

4 ACG Worldwide

6 Actylis

1 Aeon Procare

1 Alcedo Pharmachem

7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

1 Ashland

30 BASF

2 CD Formulation

15 Corel Pharma Chem

3 DFE Pharma

3 Doshion Polyscience

1 Esteem Industries

2 Finar

11 Gangwal Chemicals

12 Ideal Cures

4 Ingredion Pharma Solutions

11 Kerry

2 Keval Exports

4 Kima Chemical

6 Lonza Capsugel

11 Microlex e.U

2 Nanjing Bold Chemical

3 Nitika Pharmaceutical Specialities

2 Nomisma Healthcare

2 Novo Excipients

3 Pharmatrans-Sanaq

6 Pluviaendo

3 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

2 Qualicaps

TABLET, DELAYED RELEASE;ORAL - EQ 20MG BASE;375MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET, DELAYED RELEASE;ORAL - EQ 20MG BASE;500MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons